Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Totally Agree, Building the business, with out the Debt. Good Day ..
Ndakota
I agree they are building the business and doing a great job of it too but there would be nothing wrong with a little bit of profit either. Especially as a young company.
They are building the business. I do not want profit right now. I want them to keep making the business. 2.0 products have only been in the market for a year. The entire industry has only been legal since 2019 they have moved quickly and are building a solid company piece by piece
Oh I remember the days of the waiting for that one.
Net profits would be nice.
Sure wish mgmt was as excited about profits as they are about revenues. If they were, volume would be screaming crazy.
You and I have waited elsewhere for profits. It's heart wrenching to come up short Q after Q.
EBITDA profitable makes me grin, but net profits would really make me smile.
$ALEAF less than 100,000 to go to break it's avg 10 day volume.
I feel that we will never get out of pennies.
Comments & highlights in blue and red. --->>> Aleafia Health Repays $25M Debt with Cash, Provides Update on Sales Growth, New Product Mix
Thanks for the find 'Lucky Fellow'
A quick aside before you read the good news. There will be another shoe to drop. Again, there is no news on profits, and after this cash repayment, what is the cash position? Will they need to do another dilutive capital raise? That said, everything in today's PR is great news. - FUNMAN
https://aleafiahealth.com/news-releases/aleafia-health-repays-25m-debt-with-cash-provides-update-on-sales-growth-new-product-mix/
TORONTO, February 2, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced the full repayment in cash of its 8% unsecured convertible debt (the “Convertible Debt”), which matured on February 2, 2021. Emblem Corp., which issued the Convertible Debt on February 2, 2018, was acquired by the Company on March 14, 2019.
“Our team is excited to see continued cannabis sales growth in 2021, driven by new products launched late last year,” said Aleafia Health CEO Geoffrey Benic. “The adult-use, medical and international cannabis markets are the pillars of our 2021 growth strategy, and we look forward to capitalizing on this global opportunity through the continued expansion of our cannabis product portfolio.”
Building on record cannabis net revenue realized in the quarter ended December 31, 2020 (“Q4 2020”), the Company is pleased to report on additional near term growth opportunities across the medical, adult-use, and international sales channels.
Medical Cannabis: Q4 2020 represents Aleafia Health’s best medical cannabis sales quarter to date. The Company expects to continue this growth trajectory in 2021 with a more diverse product mix, expanded same-day delivery service which is critical during Covid-19, and through its strategic partnership with Unifor, Canada’s largest private sector union. In January, traditionally a month with slower demand, the Company observed its fourth consecutive monthly record for medical cannabis revenue.
Hopefully you wont have to cash out again from here. GL
Transparency here is key. We have some great things coming imo. Merger, buyout, up listing either way we go up from here. I think up list to get new money in here would be good. Would love to see the shorts squeezed. Large groups of investors kinda kill this for me but ive got faith. GLAL
Gap is closing gonna be a great year GLAL!!!
Alot of what we already knew.
Update payback 25mil cash an update
https://mailchi.mp/aleafiahealth.com/aleafia-health-repays-25m-debt-with-cash-provides-update-on-sales-growth-new-product-mix?e=87f442844a
So this means one more director will be resigning by JUN 30 2021. Which one is it?
Loreto Grimaldi-Chair of the HR and Compensation Committee
Daniel Milliard-Director
Lea Ray-Acting Board Chair and Chair of the Audit Committee
Mark J. Sandler-Chair of the Governance Committee
Glenn Washer-Director
I'll bet some are back at it though.
That's confirmation of the squeeze.
I'll be happy to see them go away.
Short % Increase / Decrease
-43 %
Short Interest (Shares Short)
1,311,400
Short Interest (Shares Short) - Prior
2,304,400
Exchange
NBB
Record Date
2021-JanB
Yeah it did, but we had moved up several cents so needs to consolidate for a bit. Built a new base.
Volume(Average) Today's volume of 442,151 shares is on pace to be in-line with ALEAF's 10-day average volume of 552,689 shares.
February 01, 2021 3:14pm ET
Price
$0.5601
Day's Change
0.0101 (1.84%)
Volume definitely ascended over the last few months.
They may be rounding 2nd base and looking for the 3rd base coach to wave them in.
"What If?" It has to be on their minds. Hopefully they are already thinking about what they can do.
Fun makes sense. Looking like an uplist is in store possible. Thanks for the info
Nice, they seem to have quite a bit on their minds.
1 out / 2 in --->>> Aleafia Health to Appoint Two New Independent Directors --->>> Coincidental? See Blue
Aleafia Health Inc.
Mon, February 1, 2021, 9:19 AM·5 min read
https://finance.yahoo.com/news/aleafia-health-appoint-two-independent-141900328.html
TORONTO, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that the board of directors (the “Board”) has appointed Lu Galasso and Carlo Sistilli as independent directors to the Board. Mr. Galasso will be appointed to the Strategic Planning Committee and Mr. Sistilli will be appointed to the Audit Committee.
“I would like to welcome Lu and Carlo to our Board,” said Acting Chair Lea Ray. “Their collective professional experience will bring unique skills to the Board that will serve Aleafia Health well in its continued growth.”
Lu Galasso
Lu Galasso is a Chartered Professional Accountant, CA, CPA and holds the Institute of Corporate Directors ICD.D designation.
Lu is a Partner with the Zzen Group of Companies, a company in the real estate and manufacturing sectors, where he is the CFO and head of strategic developments for the manufacturing operations.
Lu is Chair of the Board of Directors for Titanium Transportation Group, a trucking and logistics business listed on the TSX. He is also the President of the Board of Directors of the Meta Foundation, a member of the Board for the St. Christopher Children’s Home, and a member of the Dean’s Advisory Board for the Faculty of Management at Laurentian University.
Carlo Sistilli
Carlo Sistilli is a Chartered Professional Accountant and a Certified Management Accountant, CPA, CMA. As Chief Financial Officer and member of the Senior Management team of Arista Homes, Carlo plays a key role in overall operations including evaluation of mergers and acquisitions.
Prior to Arista, Carlo co-founded and served as CFO, member of the M&A team and member of the Board of Directors of an Internet start-up company, playing a key role in taking the company public on the Alberta Ventures Exchange.
Carlo is a member of the Board of Directors and Chair of the Audit Committee of Edesa Biotech, Inc., a company listed on NASDAQ. Mr. Sistilli is an officer and a member of the Board of Directors of Mother of Mercy Centre, a charity operating in Ontario.
In connection with the director appointments, the Company entered into a director nomination agreement with a group of shareholders of the Company representing approximately 15.65% of the issued and outstanding common shares of the Company pursuant to which, among other things, such shareholders have agreed to a customary standstill provision in favour of the Company until December 31, 2021 (provided that it may be terminated after the 2021 annual meeting of the shareholders of the Company (the “2021 Annual Meeting”) in certain circumstances) and to vote all of their common shares in favour of the director nominees recommended by the Company for election at the 2021 Annual Meeting, which the Company has agreed to hold no later than June 30, 2021. The Company has also agreed to nominate seven directors for election at the 2021 Annual Meeting consisting of four current directors, Messrs. Galasso and Sistilli and one independent director to be selected following a search process and approval by the Board, having regard to the Company’s corporate governance and director nomination policies and the skills matrix of the Board.
For Investor & Media Relations:
Nicholas Bergamini, VP Investor Relations
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.
Aleafia Health owns three significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.
Innovation, the heart of Aleafia Health’s competitive advantage, has led to the Company maintaining a medical cannabis dataset with over 10 million data points to inform proprietary illness-specific product development and its highly differentiated education platform FoliEdge Academy. The Company is committed to creating sustainable shareholder value; the TSX Venture Exchange named Aleafia the 2019 top performing company prior to its graduation to the TSX.
Forward Looking Information
This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
GL with your new shares.
Lucky, I don't think a buyout is what Aleafia is looking for. I see it as a natural byproduct of a successful UNIFOR deal. That said, I will believe that deal when I see revenues from Insurance companies putting Cannabis on their Formulary lists to reimburse cannabis expenditures.
A certain percentage of union members and their families are current cannabis users. A certain percentage of them have various prescriptions for things cannabis could replace.
As today's Tilray approval announcement points out, cannabis can be prescribed for quite a few common problems:
Tilray medical cannabis products are approved for the treatment of
IMO, a rapid rise in patient counts at Aleafia could result in a production squeeze not easily remedied. Buying it wholesale could be a slim gross profit bridge to cultivation expansion.
Aleafia could buy moth-balled cultivation facilities.
Aphria could step forward with an attractive buyout offer. They wouldn't have to spend an extra CAPEX penny to meet demand.
Aleafia's mgmt has to be thinking about it.
Added...back in...ALEAF!
Not sure buyout is what they are looking for. They can easily expand. That may be what the wedding cake deal was about. Also with 300000 union members the real number lies in how many have the canabis part active. Im sure they have run numbers. More importantly they need more happening in the US. Anyone see the angle on that?
This is only about signed up patients.
FUNMAN Member Level Saturday, 01/30/21 06:35:59 PM
Re: $oldier Hard post# 2721
Post # 2722 of 2730
If Aleafia lines up patients numbers anywhere near Trulieve the don’t have enough cultivation.
They will become an incredible buy out candidate.
We shouldn't have long to wait to find out regarding numbers of patients.
Yes I have to agree with you as well. This has been a crazy ride so far. Cheers
Agreed! They have navigated a very complex legal system and managed to make an amazing company under extremely challenging conditions.
Every business ends up in that place at some time or another. The emblem deal was very accretive for Aleafia. That gave them the ability to make the deal with the union and have the ability to on board patients. That good will gave them a golden ticket. If their price goes down because folks do not understand that, it jyst gives me an opportunity to buy more!
I Have to agree with you on how Lots of us became ALEAF shareholders. I was not a happy camper, I have added shares hear and there.
Benic, (CEO) has guided the company to what we are fixing to see in Q-4, Some Really Good Numbers. (In My Estimation). He is showing us some Great Progress going forward, I thought he had said we should see the Final EU Certification by the end of Jan. (he also said the Covid could bring a delay). I'm still looking for the Cert. before the Q-4 gets out. So Many Doors are going to OPEN with the Final Cert. (Unifor for me was a pleasant Surprise).
IMHO- there will be Lots of M&A coming as the Cannabis opens up, I feel Benic has added a ton of Value to ALEAF and we are going to see the Buds stat to Blossom Good Day...
Ndakota
Did you know the Emblem deal gave aleafia a large number of patients, that 160,000 sf state of the art facility, time release and branding label, all from Emblem. Infact the only reason a lot got into aleafia who by the way took our $2 and waked it down 1/3+ and said we made a profit by buying into the company while losing shares and thousands. But emblem is the problem. I would say its the farmers who have the issue with not knowing how to run a company. Its about time the board get a good shuffle and we find someone who can make us some $$. This company will be great just need a new driver with some good ability to take us up and out of short land.
Theres alot of things I like about Aleafia, but one thing I dont like is the line item of Goodwill on the balance sheet. Its huge. All because of the Emblem deal?
This is a nice reminder of the business we have a piece of, and remember they Niagara greenhouse now has its GCMP(?) compliance and they have the deal with the union. The video is a year old and they have checked more boxes
If Aleafia lines up patients numbers anywhere near Trulieve the don’t have enough cultivation.
They will become an incredible buy out candidate.
Buy out $ALEAF. Huh. That would be another company you and I owned shares in getting bought out.
If so, her job is not complete. Someone has to take the ball over the goal line and spike it.
If Aleafia successfully lines up insurance company reimbursement for cannabis, Aleafia does not have enough cultivation acreage.
Therefore, if they line up insurance company reimbursement, that might be the stimulus for a company with underutilized cultivation facilities such as Aphria and ACB to buy out Aleafia. Wouldn't that be sweet?!?!?!?!?
Maybe she was just brought on to assist in getting the deal with the unions insurance company. She has a background.
vice president of Aviva Canada Inc., Allianz Insurance Company of Canada
It seems to me there is a obvious pattern of shorting here. Soon to be eliminated. You cant stop progress. GLAL what is read here does have an effect on people buying and selling. The more chatter the better. Maybe our independent board member was inside shorting. Seem to be a fitting punishment for that type of behavior. Maybe we will start seeing more members let go so aleafia has a chance to give back to its investors. Let the good times roll.
My opinion is just that.. if we hold it it will grow. Anyone flipping will eventually miss the buss. Would be nice to see this boom.!
Im not a fan of many board members. Isnt it their job to oversee shareholders interests? Many of these people are on multiple companies board of directors. Has anyone ever communicated with a board member?
I wonder why? --->>> Aleafia Health Announces Change to Board of Directors
TORONTO, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced that Rhonda Lawson has resigned as a director of the Company.
I feel the same way. They have to cut through the noise somehow and you get the word right from the company instead of filtered through an expert. I really like what they are doing and have KinSlips on order. I will let you know how they are, I really like their vapes very partial to Zen’s Garden
It's important to note the source of articles when available. It informs the reader of bias.
I am all for Aleafia paying for investor publicity. It's advertising to attract investors. It should not be a secret. They are paying to broaden investor awareness. That's a positive. It's nothing to be embarrassed by or hidden.
If you recall, Aleafia also announced prior to announcing the agreement with StoneBridge, that Aleafia was going to stop spending money on another form of publicity which was not working effectively.
Anyone following Aleafia already knew of the article's contents.
I posted it because the article was a terrific summary.
I will continue to post the good, the bad, and the ugly.
For now I await the year end ER to learn how much revenues are north or south of $15M, and if they can squeeze a profit out on the bottom line.
I would be happy if Aleafia gave us profit guidance.
Paid for articles don't need to be seen as a negative. I thought this article was well written and informative without a lot of chest beating. Paid for articles also get the word out to the public without the company needing to write a somewhat similar article about itself.
If I had posted this article on I-Hub, I probably wouldn't have highlighted "Paid for Article" in red as you did. But, thank you for posting!
All in all, I thought this was a good article. Nice to see.
Thank you for this!
Followers
|
84
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3371
|
Created
|
12/08/16
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |